Compare DCI Indonesia Tbk (DCII) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DCI Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? DCI Indonesia Tbk trades at Rp206,000 (market cap 491.05T, 700 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 753.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (848.2K versus 700). Which is the better fit depends on your goals.
| DCII | LABS | |
|---|---|---|
Market Cap | 491.05T | 651.75B |
Volume | 700 | 848.2K |
Lot | 7 | 8.48K |
Turnover | 144.2M | 140.51M |
Average Price | 206,000 | 165.66 |
Value | 144.2M | 140.51M |
Indicative Equilibrium Price | — | 168 |
Indicative Equilibrium Volume | — | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DCI Indonesia Tbk
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Read more on DCII →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
